Product image of Minette (Chlormadinone Acetate, Ethinylestradiol) supplied by GNH India

Minette

Active Ingredient:
Chlormadinone Acetate, Ethinylestradiol
Origin:
EU

Minette (Chlormadinone Acetate, Ethinylestradiol)

Chlormadinone acetate, the active ingredient in Minette, is a combined oral contraceptive (progestogen and estrogen) presented as a tablet for oral use. It is prescribed to prevent pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus.

GNH India supplies Minette as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality manufacturing, regulatory compliance across EU and global markets, and providing reliable sourcing, batch testing, and documentation to meet the needs of healthcare providers.

Manufacturer / TM Owner

Besins Healthcare Germany Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Minette is a combined oral contraceptive that works on the hypothalamic‑pituitary‑ovarian axis to prevent pregnancy.

  • Prevention of pregnancy: provides reliable contraception for women of child‑bearing potential by suppressing ovulation and modifying cervical mucus.

How It Works

  • Chlormadinone acetate acts as a progestogenic agent that binds to progesterone receptors, while ethinylestradiol provides estrogenic activity. Together they suppress the hypothalamic‑pituitary‑ovarian axis, reducing the release of luteinising hormone (LH) and follicle‑stimulating hormone (FSH), thereby preventing follicular development and ovulation. The combination also thickens cervical mucus and induces endometrial changes that hinder implantation.

Side Effects

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Breast tenderness: discomfort or swelling of the breasts.
  • Headache: occasional mild to moderate pain.
  • Weight gain: slight increase in body weight.
  • Mood changes: irritability or mild mood swings.
  • Spotting between periods: irregular light bleeding.

Serious or Rare Side Effects

  • Venous thromboembolism: deep vein thrombosis or pulmonary embolism.
  • Arterial thrombosis: stroke or myocardial infarction.
  • Hypertension: new or worsening high blood pressure.
  • Liver dysfunction: jaundice or hepatic adenoma.
  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Visual disturbances: sudden vision changes or loss.

Precautions & Warnings

Before prescribing Minette, clinicians should assess individual risk factors and counsel patients on safe use.

  • VTE risk assessment: evaluate personal or family history of clotting disorders.
  • Smoking cessation: advise women over 35 who smoke to quit.
  • Liver disease monitoring: avoid use in active liver disease.
  • Blood pressure check: monitor for hypertension during therapy.
  • Drug interaction review: verify concomitant medications that may affect efficacy.
  • Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Minette may interact with several medicines that alter hormone metabolism.

Major Interactions (Avoid)

  • Strong CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin): may reduce contraceptive effectiveness.
  • Certain antiretrovirals (e.g., efavirenz): can lower hormone levels.
  • St. John’s wort: potent CYP3A4 inducer, decreasing efficacy.

Moderate Interactions (Monitor Closely)

  • Moderate CYP3A4 inducers (e.g., griseofulvin, phenobarbital): may modestly reduce effectiveness.
  • Antibiotics such as tetracycline or metronidazole: occasional reduction in hormone levels.
  • Antifungal agents (e.g., fluconazole): may increase hormone concentrations, watch for side effects.

Frequently Asked Questions

Minette is a combined oral contraceptive containing chlormadinone acetate and ethinylestradiol. It is used to prevent pregnancy in women of reproductive age by suppressing ovulation and altering cervical mucus to impede sperm penetration.

Chlormadinone acetate acts as a progestogen, binding to progesterone receptors and inhibiting the hypothalamic‑pituitary‑ovarian axis. This reduces luteinising hormone and follicle‑stimulating hormone release, preventing follicular development and ovulation.

The dosing regimen for Minette is determined by the prescribing healthcare professional. The prescriber selects the appropriate tablet strength and schedule based on the patient’s clinical needs and regulatory guidelines.

Minette is contraindicated in pregnancy and should not be started in women who are already pregnant. It is generally not recommended during breastfeeding because hormonal contraceptives can affect milk production and infant exposure.

To order Minette, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Minette contains chlormadinone acetate, a progestogen with a slightly higher anti‑androgenic profile, combined with ethinylestradiol. Compared with other combined pills that use levonorgestrel or desogestrel, Minette may offer different bleeding patterns and side‑effect profiles, but overall efficacy in preventing pregnancy is comparable.

Store Minette tablets at temperatures below 25 °C in their original packaging. Protect them from moisture, excessive heat and direct sunlight to maintain product stability throughout its shelf life.

Minette is taken orally, usually once daily at the same time each day, as directed by the prescriber. The tablets are swallowed with water and should not be chewed or broken.

The most serious risks include venous thromboembolism, arterial thrombosis (such as stroke or myocardial infarction), severe hypertension, and rare liver disorders. Patients should seek immediate medical attention if they experience symptoms like sudden leg pain, chest pain, severe headache, or visual changes.

Minette is contraindicated in women who are pregnant, have a history of thromboembolic disorders, uncontrolled hypertension, active liver disease, known or suspected breast cancer, or who are smokers over the age of 35. It should also be avoided in individuals with known hypersensitivity to any component of the product.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Chlormadinone Acetate, Ethinylestradiol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT